Total Payments
$630.70
2024 Payments
$149.59
Companies
12
Transactions
14
Medicare Patients
1,348
Medicare Billing
$203,413
Payment Breakdown by Category
Food & Beverage$383.73 (60.8%)
Education$246.97 (39.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $383.73 | 9 | 60.8% |
| Education | $246.97 | 5 | 39.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $114.48 | 1 | $0 (2024) |
| Janssen Biotech, Inc. | $99.99 | 1 | $0 (2020) |
| Incyte Corporation | $99.95 | 1 | $0 (2018) |
| Genentech USA, Inc. | $95.42 | 2 | $0 (2018) |
| Celgene Corporation | $69.06 | 1 | $0 (2019) |
| Merck Sharp & Dohme LLC | $36.67 | 2 | $0 (2024) |
| BeiGene USA, Inc. | $35.00 | 1 | $0 (2023) |
| Amgen Inc. | $27.37 | 1 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $17.02 | 1 | $0 (2024) |
| EMD Serono, Inc. | $11.99 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $149.59 | 3 | E.R. Squibb & Sons, L.L.C. ($114.48) |
| 2023 | $35.00 | 1 | BeiGene USA, Inc. ($35.00) |
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
| 2020 | $99.99 | 1 | Janssen Biotech, Inc. ($99.99) |
| 2019 | $115.01 | 3 | Celgene Corporation ($69.06) |
| 2018 | $111.15 | 2 | Incyte Corporation ($99.95) |
| 2017 | $108.04 | 3 | Genentech USA, Inc. ($84.22) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/02/2024 | Merck Sharp & Dohme LLC | WELIREG (Drug) | Education | In-kind items and services | $18.09 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Education | In-kind items and services | $17.02 | General |
| Category: ONCOLOGY | ||||||
| 02/22/2024 | E.R. Squibb & Sons, L.L.C. | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $114.48 | General |
| Category: Hematology | ||||||
| 11/15/2023 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Oncology | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 02/20/2020 | Janssen Biotech, Inc. | ERLEADA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Oncology | ||||||
| 07/25/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: ONCOLOGY | ||||||
| 04/23/2019 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $69.06 | General |
| Category: Hematology / Oncology | ||||||
| 01/10/2019 | Amgen Inc. | Vectibix (Biological) | Food and Beverage | In-kind items and services | $27.37 | General |
| Category: Oncology | ||||||
| 11/14/2018 | Incyte Corporation | — | Education | Cash or cash equivalent | $99.95 | General |
| 10/24/2018 | Genentech USA, Inc. | Perjeta (Biological), Kadcyla | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: BioOncology | ||||||
| 07/12/2017 | EMD Serono, Inc. | Bavencio (Biological) | Food and Beverage | Cash or cash equivalent | $11.99 | General |
| Category: Oncology | ||||||
| 04/25/2017 | Genentech USA, Inc. | GAZYVA (Biological) | Food and Beverage | In-kind items and services | $84.22 | General |
| Category: BioOncology | ||||||
| 02/13/2017 | ARIAD Pharmaceuticals, Inc. | Iclusig (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Not Applicable | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 262 | 493 | $72,547 | $40,309 |
| 2022 | 7 | 301 | 556 | $85,295 | $47,743 |
| 2021 | 10 | 356 | 734 | $107,555 | $59,931 |
| 2020 | 11 | 429 | 770 | $109,671 | $55,431 |
Total Patients
1,348
Total Services
2,553
Medicare Billing
$203,413
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 119 | 250 | $26,367 | $17,474 | 66.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 54 | 134 | $20,770 | $13,844 | 66.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 18 | 18 | $3,546 | $2,445 | 68.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 38 | $8,664 | $2,315 | 26.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 23 | $9,936 | $2,307 | 23.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 14 | 14 | $2,142 | $1,287 | 60.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 13 | 16 | $1,122 | $636.69 | 56.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 134 | 294 | $31,298 | $21,608 | 69.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 66 | 140 | $22,449 | $15,612 | 69.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 26 | 26 | $5,122 | $3,536 | 69.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 21 | 41 | $9,348 | $2,288 | 24.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $8,320 | $1,951 | 23.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 16 | 16 | $6,912 | $1,480 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 25 | 26 | $1,846 | $1,268 | 68.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 131 | 391 | $41,162 | $30,227 | 73.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 56 | 120 | $18,600 | $13,821 | 74.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 39 | 79 | $18,012 | $4,492 | 24.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 32 | 32 | $13,824 | $3,444 | 24.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 19 | 19 | $3,743 | $2,723 | 72.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 31 | 35 | $2,485 | $1,811 | 72.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 11 | 19 | $6,194 | $1,552 | 25.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 13 | 13 | $1,992 | $1,142 | 57.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 12 | 12 | $997.00 | $432.56 | 43.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 12 | 14 | $546.00 | $287.00 | 52.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 168 | 410 | $36,223 | $24,679 | 68.1% |
About Dr. Joann Hirth, MD
Dr. Joann Hirth, MD is a Hematology & Oncology healthcare provider based in Jackson, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821063363.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joann Hirth, MD has received a total of $630.70 in payments from pharmaceutical and medical device companies, with $149.59 received in 2024. These payments were reported across 14 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($383.73).
As a Medicare-enrolled provider, Hirth has provided services to 1,348 Medicare beneficiaries, totaling 2,553 services with total Medicare billing of $203,413. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Jackson, MI
- Active Since 02/20/2006
- Last Updated 08/08/2023
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1821063363
Products in Payments
- REBLOZYL (Biological) $114.48
- ERLEADA (Drug) $99.99
- GAZYVA (Biological) $84.22
- Revlimid (Drug) $69.06
- BRUKINSA (Drug) $35.00
- Vectibix (Biological) $27.37
- KEYTRUDA (Biological) $18.58
- WELIREG (Drug) $18.09
- LIBTAYO (Biological) $17.02
- Bavencio (Biological) $11.99
- Iclusig (Drug) $11.83
- Perjeta (Biological) $11.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Jackson
Guangzhi Qu, M.d, M.D
Hematology & Oncology — Payments: $55,663
Hematology & Oncology $55,663
John Henegan, M.d, M.D
Hematology & Oncology — Payments: $36,081
Hematology & Oncology $36,081
Gary Shi, Md, Phd, MD, PHD
Hematology & Oncology — Payments: $17,681
Hematology & Oncology $17,681
Barbara Craft, Md, MD
Hematology & Oncology — Payments: $17,539
Hematology & Oncology $17,539
Grace Shumaker, M.d, M.D
Hematology & Oncology — Payments: $5,378
Hematology & Oncology $5,378
Bobby Wilkerson, M.d, M.D
Hematology & Oncology — Payments: $4,514
Hematology & Oncology $4,514